Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01892969 · ClinicalTrials.gov registry record
Coagulation and Fibrinolysis in Pediatric Insulin Titration Trial (CAF-PINT)
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 304
- Enrollment target
NCT01892969 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 304 participants.
The verdict
NCT01892969 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 304 participants
- Enrollment target
Study Summary
Project Summary We propose an ancillary study to The Heart and Lung Failure Pediatric Insulin Titration trial (HALF PINT), which is investigating the impact of normalizing blood glucose using insulin infusions on clinical outcomes among children with hyperglycemia and heart and lung failure. In this ancillary study, we will measure plasma levels of inflammatory, coagulation, and fibrinolysis proteins and genotype DNA for polymorphisms among patients enrolled in the HALF PINT trial. The results from this ancillary study will help us to understand potential mechanisms through which normalizing blood glucose provides benefit, which may lead to development of new therapeutic strategies in critically ill children
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2012-10 |
| Est. Completion | 2016-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01892969
The ClinicalTrials.gov registry entry for NCT01892969 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 304 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01892969 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01892969 about?
NCT01892969 is a clinical study titled "Coagulation and Fibrinolysis in Pediatric Insulin Titration Trial (CAF-PINT)". Project Summary We propose an ancillary study to The Heart and Lung Failure Pediatric Insulin Titration trial (HALF PINT), which is investigating the impact of normalizing blood glucose using insulin infusions on clinical outcomes among children with hyperglycemia and heart and lung failure. In this...
What is the current status of trial NCT01892969?
This trial is currently completed. The enrollment target is 304 participants. The study started on 2012-10. Estimated completion is 2016-09.
Who is sponsoring clinical trial NCT01892969?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.